Sign in Subscribe
Scientists

Soy Isoflavones Show Promise in Treating Adult T-Cell Leukemia

Strategic Insights

— 1 min read

A recent study published in the journal Cancer Science has shed light on the potential benefits of soy isoflavones in treating adult T-cell leukemia. Researchers from Miyazaki University discovered that genistein, a type of soy isoflavone, exhibited biphasic growth-inhibitory properties, preventing the growth of cancer cells in both in vitro and in vivo studies. The findings suggest that soy isoflavones may serve as a promising compound for the treatment of adult T-cell leukemia.

Key Takeaways:

  • Genistein, a type of soy isoflavone, significantly inhibited the proliferation of adult T-cell leukemia cells in a dose-dependent manner.
  • The in vitro study showed that daidzein and genistein, but not glycitein, inhibited the growth of ED-40515 and Hut102 cells.
  • Genistein upregulated p21 protein expression and p53 accumulation, indicating its potential as a therapeutic agent for adult T-cell leukemia.
  • The in vivo study demonstrated that soy-derived isoflavones inhibited the growth of ED-40515 cell growth and infiltration into various organs in non-obese diabetic severe combined-immunodeficiency common gamma-chain knockout mice.
  • The researchers concluded that soy isoflavones might serve as a promising compound for the treatment of adult T-cell leukemia.
  • The study's findings have significant implications for the potential use of genistein in treating adult T-cell leukemia, a disease that is endemic to the south-western area of Kyushu in Japan.

Statistics:

  • 30 mc M genistein strongly induced phosphorylation of checkpoint kinase (CHK) 2 and p53 at serines 15, 20, and 37.
  • 3 and 10 mc M genistein prevented the G(1)/S or G(2)/M transition, respectively.
  • 30 mc M genistein treated mice showed a significant reduction in ED-40515 cell growth and infiltration into various organs.
  • The study was published in Cancer Science (vol. 98, no. 11, 2007), with a total of 1740-1746 pages.

Sources:

  • Yamasaki, M., et al. (2007). Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Science, 98(11), 1740-1746.
  • Miyazaki University (Faculty of Agriculture, Department of Biochemistry and Applied Bioscience). Contact: K. Nishiyama, 1-1 Gakuenkibanadai-nishi, Miyazaki 88921, Japan.
  • Blackwell Publishing (Publisher of Cancer Science). Contact: 9600 Garsington Rd., Oxford OX4 2DQ, Oxon, England.

Read more